Wave Life Sciences Stock Quote WVE - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

5.68

Bid

5.40

Ask

6.38

Volume

1,777,723

5.68 Day's Range 6.02

3.50 52 Week Range 7.67

Market Cap

708.511M

Previous Close

5.94

Open

5.95

Last Trade

1358

5.68

Last Trade Time

Financial Volume

$ 10,469,962

VWAP

5.8895

Average Volume (3m)

619,572

Shares Outstanding

124,737,862

Dividend Yield

PE Ratio

-12.32

Earnings Per Share (EPS)

-0.46

Revenue

115.18M

Net Profit

-57.51M

WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.wavelifesciences.com

Headquarters

Singapore, Sgp

Founded

Wave Life Sciences Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker WVE. The last closing price for Wave Life Sciences was $5.94. Over the last year, Wave Life Sciences shares have traded in a share price range of $ 3.50 to $ 7.67.

Wave Life Sciences currently has 124,737,862 shares outstanding. The market capitalization of Wave Life Sciences is $740.94 million. Wave Life Sciences has a price to earnings ratio (PE ratio) of -12.32.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy

Designation highlights significant unmet needs in DMD; dystrophin data from potentially registrational FORWARD-53 trial of WVE-N531 are on track for 3Q 2024 In previous Part A trial, WVE-N531...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.22	-3.72881355932	5.9	6.07	5.47	498743	5.81224526	CS
4	0.11	1.97486535009	5.57	6.15	5.04	498461	5.70009036	CS
12	0.74	14.979757085	4.94	6.855	4.87	619572	5.8390717	CS
26	-0.22	-3.72881355932	5.9	6.855	4.25	710770	5.6449461	CS
52	0.34	6.3670411985	5.34	7.67	3.5	726305	5.42512943	CS
156	0.1	1.79211469534	5.58	7.67	1.16	538362	4.54155296	CS
260	-19.01	-76.9947347104	24.69	39.99	1.16	604823	6.96717821	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BNZIBanzai International Inc	$ 5.645 (96.01%)	61.39M
ZJYLJin Medical International Ltd	$ 3.975 (50.00%)	1.24M
ANEBAnebulo Pharmaceuticals Inc	$ 2.9001 (39.43%)	78.85k
XPONExpion360 Inc	$ 0.081 (39.18%)	1.46B
AENTAlliance Entertainment Holding Corporation	$ 2.74 (34.31%)	4.23M
GSIWGarden Stage Ltd	$ 1.34 (-82.89%)	26.44M
CRBPCorbus Pharmaceuticals Holdings Inc	$ 19.51 (-62.26%)	12.29M
LGCBLinkage Global Inc	$ 0.4183 (-57.70%)	2.16M
BFIBurgerFi International Inc	$ 0.0855 (-42.27%)	15.05M
SKYESkye Bioscience Inc	$ 3.17 (-42.26%)	5.14M
XPONExpion360 Inc	$ 0.081 (39.18%)	1.46B
NVDANVIDIA Corporation	$ 116.00 (-1.59%)	378.16M
AAPLApple Inc	$ 228.20 (-0.29%)	320.24M
INTCIntel Corporation	$ 21.84 (3.31%)	261.68M
VERBVerb Technology Company Inc	$ 0.0742 (33.45%)	178.65M